2025-05-16 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the data provided, presented as a report:

**Report on Colgate-Palmolive Co. (CL)**

**1. Relative Performance vs. S&P 500 (VOO)**

*   **Ticker:** CL
*   **Company Overview:** Colgate-Palmolive Co. is a global consumer products company focused on the production, distribution, and provision of household, health care, and personal care products.
*   **CL Cumulative Return:** 24.06%
*   **VOO Cumulative Return:** 81.82%
*   **Absolute Divergence (CL - VOO):** -57.76%
*   **Relative Divergence:** 9.7 (Indicates CL's performance is at the lower end of its historical range compared to VOO)

**Analysis:** CL has significantly underperformed the S&P 500 over the period, with a substantial negative divergence. The relative divergence suggests this underperformance is near the lower extreme of its historical relationship with the S&P 500.

**Alpha/Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha  | Beta | Cap(B) |
|------------|-------|-------|--------|------|--------|
| 2015-2017  | 13.0% | 4.8%  | -16.0% | 0.1  | 51.2   |
| 2016-2018  | -11.0% | 65.2% | -29.0% | 0.1  | 41.4   |
| 2017-2019  | 7.0%  | 65.2% | -22.0% | 0.2  | 49.1   |
| 2018-2020  | 18.0% | 65.2% | -8.0%  | 0.7  | 62.4   |
| 2019-2021  | 30.0% | 58.6% | -25.0% | 1.0  | 63.7   |
| 2020-2022  | 8.0%  | 69.0% | 1.0%   | 1.0  | 60.3   |
| 2021-2023  | 8.0%  | 69.0% | -9.0%  | 0.9  | 62.5   |
| 2022-2024  | 15.0% | 69.0% | -2.0%  | 0.8  | 72.9   |
| 2023-2025  | 10.0% | 73.5% | -19.0% | 0.3  | 72.3   |

**Analysis:**

*   **CAGR:** Varies, showing periods of strong growth and decline.
*   **MDD:** Relatively high Maximum Drawdown figures suggest significant volatility in some periods.
*   **Alpha:** Consistently negative alpha values indicate underperformance relative to a market benchmark, except for 2020-2022.
*   **Beta:** Low Beta values generally indicate lower sensitivity to market movements.
*   **Market Cap:** Market cap is generally increasing over time

**2. Recent Price Action**

*   **Current Price:** 89.17
*   **Last Market Data:** Price: 89.23, Previous Close: 87.57, Change: 1.9 (Notable positive change)
*   **5-day Moving Average:** 89.97
*   **20-day Moving Average:** 92.07
*   **60-day Moving Average:** 91.37

**Analysis:** The current price is below both the 20-day and 60-day moving averages, suggesting a short-term downtrend. However, the recent positive change from the last market indicates a potential short-term rebound.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.35 (Low Risk)
*   **RSI:** 28.51 (Oversold)
*   **PPO:** -0.45
*   **20-day Relative Divergence Change:** -13.0 (Short-term decrease)
*   **Expected Return:** -349.0%

**Analysis:**

*   The RSI in oversold territory might signal a potential buying opportunity, although it can remain oversold for extended periods.
*   The negative PPO and decreasing relative divergence reinforce the recent downtrend.
*   **Expected Return:** The extremely negative expected return is an outlier, indicating significant future underperformance relative to the S&P 500 based on this model.

**4. Recent News & Significant Events**

*   **News:**
    *   Major business developments, regulatory changes, or market events.
    *   Analyst discussions about recent performance and outlook.
    *   Notable stock volatility influenced by recent events.
    *   Market experts highlighting both risks and opportunities.

**Analysis:** The news highlights both opportunities and risks, with stock volatility mentioned. This suggests investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| 날짜         | EPS  | 매출       |
|--------------|------|------------|
| 2025-04-25 | 0.85 | 4.91 B$    |
| 2024-10-25 | 0.9  | 5.03 B$    |
| 2024-07-26 | 0.89 | 5.06 B$    |
| 2024-04-26 | 0.83 | 5.07 B$    |
| 2025-04-25 | 0.83 | 5.07 B$    |

**Analysis:**

*   **EPS:** EPS is relatively stable, fluctuating slightly over the reported quarters.
*   **Revenue:** Revenue has shown a slight decline recently.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31 | $4.91B   | 60.82%        |
| 2024-12-31 | $4.95B   | 60.30%        |
| 2024-09-30 | $5.03B   | 61.08%        |
| 2024-06-30 | $5.06B   | 60.62%        |
| 2024-03-31 | $5.07B   | 60.00%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-03-31 | $0.36B   | 190.08%   |
| 2024-12-31 | $0.21B   | 348.58%   |
| 2024-09-30 | $0.43B   | 169.43%   |
| 2024-06-30 | $0.12B   | 594.31%   |
| 2024-03-31 | $0.23B   | 296.96%   |

**Analysis:**

*   **Revenue and Profit Margin:**  Revenue has been slightly decreasing, while profit margins remain consistently high, indicating strong cost management.
*   **Equity and ROE:** Equity fluctuates, and ROE is exceptionally high, which could indicate either strong profitability or potentially unsustainable financial leverage.

**7. Overall Assessment**

Colgate-Palmolive (CL) presents a mixed picture.

*   **Negative Factors:** It has significantly underperformed the S&P 500, with a consistently negative alpha. Technical indicators point to a recent downtrend and oversold conditions. The extremely negative expected return is concerning.
*   **Positive Factors:** The company maintains high profit margins and a "Low Risk" MRI. The recent positive price movement may signal a short-term reversal. The oversold RSI also presents a buying opportunity to some investors.
*   **Neutral Factors:** The recent earnings data shows a mixed trend, with stable EPS but slightly decreasing revenue.

**Conclusion:**

Based on this analysis, CL appears to be facing headwinds, including underperformance relative to the market and a recent downtrend. Investors should carefully consider the negative factors and monitor the situation closely. Focus on the news regarding significant events for the company. Further investigation is needed to determine the reasons for the recent underperformance and extremely negative expected return. Additionally, while the high ROE figures might appear attractive, further scrutiny of the company's capital structure is necessary to determine the underlying drivers and sustainability of these levels.
